Cas:132487-40-2 (1s,2r)-(-)-2-aminocyclohex-3-enecarboxylic acid hydrochloride manufacturer & supplier

Chemical Name:(1s,2r)-(-)-2-aminocyclohex-3-enecarboxylic acid hydrochloride

CAS.NO:132487-40-2

Synonyms:MFCD04112726

Molecular Formula:C₇H₁₂ClNO₂

Molecular Weight:177.62900

HS Code:

Physical and Chemical Properties:

Melting point:192-209ºC

Boiling point:285ºC at 760mmHg

Density:1.18g/cm3

Index of Refraction:

PSA:63.32000

Exact Mass:177.05600

LogP:1.86680

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD04112726 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD04112726 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD04112726 Use and application,MFCD04112726 technical grade,usp/ep/jp grade.

Related News: Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. 1-(7-hydroperoxy-44,53,64,74,83,94-pentaoxolo[2,1]hexaoxin-6-yl)-24-tetraoxidan-2-one manufacturers Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform. 6-(3-chloro-phenylamino)-N-cyclobutylmethyl-2-trifluoromethyl-nicotinamide suppliers Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform. [3-methoxy-4-(2-methoxycarbonylcyclopropyl)phenoxy]acetic acid vendor & factory Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. ,The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing.